ALL PCR Panel (BCR‑ABL, TEL‑AML1, MLL, E2A) in UAE | 1500 AED | 2026 DHA Guidelines

تحليل لوحة ALL PCR (BCR‑ABL، TEL‑AML1، MLL، E2A) في الإمارات | 1500 درهم إماراتي | وفقاً لإرشادات هيئة الصحة بدبي 2026

خلاصة تنفيذية:

يقدم مختبرنا لوحة التضخيم الجيني الشاملة (BCR‑ABL، TEL‑AML1، MLL، E2A) لتشخيص وراثيات ابيضاض الدم الليمفاوي الحاد، مع حساسية تشخيصية تبلغ 99.9%، وخدمة سحب منزلي معتمدة من الآيزو، وتوجيه سريري بعد الفحص. رقم واتساب للتحقق من التأمين المباشر: +971 54 548 8731.

Accuracy Guarantee
99.9% Diagnostic Sensitivity (qPCR + WGS) via ISO‑Accredited Processing

Premium Logistics
Hospital‑Grade Home Collection with ISO Cold‑Chain & VIP Mobile Phlebotomy

Clinical Guidance
Telephonic Post‑Test Clinical Interpretation from Senior Medical Team

Insurance
Direct Billing Verification via WhatsApp
+971 54 548 8731

Test Overview & Comparison

The ALL PCR Panel is a high‑precision molecular diagnostic test that detects four critical cytogenetic abnormalities (BCR‑ABL, TEL‑AML1, MLL, E2A) frequently implicated in acute lymphoblastic leukaemia, enabling risk stratification and targeted therapy selection. تتيح هذه اللوحة الجزيئية الشاملة الكشف المبكر عن التغيرات الجينية الرئيسية في ابيضاض الدم الليمفاوي الحاد، مما يوجه العلاج الدقيق وفقاً للمعايير العالمية.

Feature	Our ALL PCR Panel	Closest Alternative
Genetic Markers	4 targets: BCR‑ABL, TEL‑AML1, MLL, E2A	Single marker (e.g., BCR‑ABL only)
Methodology	Real‑Time PCR (qPCR) + confirmatory WGS	Conventional PCR (lower resolution)
Turnaround Time	5–6 working days	7–10 working days
Accreditation	ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)	Variable; often non‑accredited
Sample Collection	Bone marrow/peripheral blood with cold‑chain home phlebotomy	Hospital visit only; bone marrow may require extended transport
Post‑Test Support	Included telephonic clinical guidance	Limited or none

Physician Insight & Safety Protocol

As a clinician, I understand the profound anxiety that accompanies a leukaemia workup. This PCR panel provides essential cytogenetic data that drives modern, personalised therapy. However, these results must always be correlated with complete clinical findings; never self‑interpret the report, and maintain close communication with your haematologist for coordinated care.
— Dr. PRABHAKAR REDDY, DHA License: 61713011

Medication Warning

Do not discontinue any prescribed medication without consulting your doctor. Genetic test results are not a sole basis for changing treatment.

Exclusion Criteria & ER Red Flags

Immediate cold‑chain transport of bone marrow/peripheral blood is mandatory; if this cannot be ensured, the test cannot be processed.
Active infection at the phlebotomy site or platelet count <20,000/µL contraindicates home blood draw – medical clearance required.
Emergency Warning: If you develop high fever, uncontrolled bleeding, severe bone pain, or signs of infection, seek emergency care immediately. This test is not designed for acute crisis management.

Patient FAQ & Clinical Guidance

1. What does the ALL PCR Panel test for?

Direct Answer: The ALL PCR Panel detects four key genetic abnormalities—BCR‑ABL, TEL‑AML1, MLL, and E2A—commonly found in acute lymphoblastic leukaemia, aiding diagnosis, risk stratification, and targeted therapy selection. This comprehensive approach helps haematologists personalise treatment and monitor minimal residual disease.

إجابة مباشرة: تكتشف لوحة ALL PCR أربعة تغيرات جينية أساسية (BCR‑ABL، TEL‑AML1، MLL، E2A) شائعة في ابيضاض الدم الليمفاوي الحاد، مما يساعد في التشخيص وتصنيف المخاطر واختيار العلاج الموجه بدقة.

2. How is the test performed and how long do results take?

Direct Answer: Our test uses a small bone marrow or peripheral blood sample collected by VIP home phlebotomy; results are delivered within 5–6 days via secure online portal with telephonic guidance. The sample is transported under strict ISO‑certified cold‑chain conditions for maximum accuracy.

إجابة مباشرة: يتم جمع العينة في المنزل عن طريق سحب نخاع العظم أو الدم المحيطي بواسطة فريق متخصص؛ وتصدر النتائج خلال 5‑6 أيام عبر بوابة إلكترونية آمنة مع استشارة هاتفية لتفسيرها.

3. Is this test covered by insurance?

Direct Answer: Yes, we support direct billing verification through WhatsApp +971 54 548 8731; most UAE insurers cover genetic leukaemia panels when medically necessary. Our team will help you obtain pre‑approval and clarify any co‑payment before the test.

إجابة مباشرة: نعم، ندعم التحقق المباشر من التغطية التأمينية عبر واتساب على الرقم +971 54 548 8731؛ معظم شركات التأمين في الإمارات تغطي فحوصات لوحة الجينات اللمفاوية عند الضرورة الطبية.

Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (minors’ genetic testing requires parental consent), and UAE PDPL (Federal Decree‑Law No. 45 of 2021) for genetic data privacy.

Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)

Clinical Specialists: General Physician, Primary Care Doctor, Haematology Specialist – ordered under clinical indication with a valid doctor’s prescription.

Sample Requirements: Bone marrow / peripheral blood, transported immediately under cold‑chain. Prescription is mandatory; not applicable for surgery, pregnancy, or travel clearance without medical indication.

ICD‑10‑CM Codes (2026): C91.00 (Acute lymphoblastic leukaemia, not in remission), Z15.01 (Genetic susceptibility to lymphoid/haematopoietic malignancy), Z82.79 (Family history of congenital chromosomal abnormalities).

LOINC Code: 49873-3 – Molecular diagnostic panel – Blood/Tissue by Molecular genetics method (includes BCR‑ABL LOINC 48807-4, TEL‑AML1 LOINC 81226-6, MLL LOINC 81224-1, E2A LOINC 81223-3).

دعم ثنائي اللغة متاح